Antibiotics after kidney injury to prevent infections
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if taking a common antibiotic (TMP/SMX) after a kidney injury can help prevent infections after you leave the hospital. It might be an option if you had acute kidney injury during your hospital stay and are being discharged to recover at home or a rehabilitation facility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had acute kidney injury (sudden kidney trouble) during your hospital stay.
- You are being discharged to home or a rehab center where follow-up is possible.
- You are able to understand and agree to the study.
- You are not allergic to sulfa drugs or TMP/SMX.
- You are not pregnant or breastfeeding, and do not have severe liver disease or very low blood counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help you stay healthy after hospitalization for acute kidney injury (a temporary loss of kidney function). The program includes better communication between your hospital and outpatient doctors, education about your kidney health, and coordinated care to prevent complications.
This trial tests if the drug AST-120 (Kremezin) can help protect your kidneys and slow down further kidney decline after a recent acute kidney injury. It is for people who had a moderate to severe kidney injury during a hospital stay and now have mild to moderate chronic kidney damage.
This trial tests whether continuing or stopping a specific antibiotic (TMP-SMX) after the first 6 months can prevent urinary tract infections (UTIs) in kidney transplant recipients who are at high risk for them.
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
This study tests different ways to customize the dose of anti-infection medicines in patients very soon after a kidney transplant to find the safest and most effective dosing. It aims to improve recovery and avoid problems with kidney function.
This study compares two different doses of an antibiotic (TMP-SMX) to prevent a serious lung infection called Pneumocystis pneumonia that can occur after kidney transplant. The goal is to find the safest, most effective dose for transplant patients.
Hear when a new Acute Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.